青云翻译

Sunitinib is a small molecule multi-target anticancer drugs, whose main mechanism is inhibition of vascular endothelial growth factor receptor, Sutent could further improve the efficacy of imatinib in combination with chemotherapy.

Sunitinib is a small molecule multi-targeting antitumor drug, the main mechanism is the inhibition of vascular endothelial growth factor receptor, sunitinib and chemotherapy could further improve the curative effect.

Shu Niti the Nepal is one kind of small molecular multi-target anti-tumor medicine, is its main mechanism suppresses the blood vessel growth factor acceptor, whether Shu Niti the Nepal union chemotherapy further enhances the curative effect.

L'Occitane, alternate, is a small molecule more target anti-cancer medicines, the main mechanism is to inhibit blood vessel growth factor receptors, L'Occitane, joint replacement, chemotherapy can further increase efficacy.

Sunitinib is a small molecule multi-targeting antitumor drug, the main mechanism is the inhibition of vascular endothelial growth factor receptor, sunitinib and chemotherapy could further improve the curative effect.